SCM
Silverarc Capital Management Portfolio holdings
AUM
$489M
1-Year Return
71.55%
This Quarter Return
+25.14%
1 Year Return
+71.55%
3 Year Return
+1,109.63%
5 Year Return
–
10 Year Return
–
AUM
$178M
AUM Growth
+$14.7M
(+9%)
Cap. Flow
+$8.85M
Cap. Flow
% of AUM
4.96%
Top 10 Holdings %
Top 10 Hldgs %
33.95%
Holding
106
New
24
Increased
27
Reduced
29
Closed
17
Top Buys
| 1 |
Aclaris Therapeutics
ACRS
|
$8.49M |
| 2 |
RACB
Research Alliance Corp. II Class A Common Stock
RACB
|
$5.13M |
| 3 |
Merus
MRUS
|
$5.11M |
| 4 |
MSACU
Medicus Sciences Acquisition Corp. Unit
MSACU
|
$4.01M |
| 5 |
Aldeyra Therapeutics
ALDX
|
$3.82M |
Top Sells
| 1 |
Vericel Corp
VCEL
|
$8.84M |
| 2 |
ESSA Pharma
EPIX
|
$7.25M |
| 3 |
Sutro Biopharma
STRO
|
$4.02M |
| 4 |
Delcath Systems
DCTH
|
$3.87M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$2.57M |
Sector Composition
| 1 | Healthcare | 88.22% |
| 2 | Financials | 2.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
101
Sutro Biopharma
STRO
$89.9M
| – | – |
-185,000
| Closed | -$4.02M |
|
102
VYNE Therapeutics
VYNE
$7.62M
| – | – |
-4,856
| Closed | -$552K |
|
103
Zentalis Pharmaceuticals
ZNTL
$126M
| – | – |
-10,000
| Closed | -$519K |
|
104
Zymeworks
ZYME
$1.14B
| – | – |
-30,834
| Closed | -$1.46M |
|
|
BNGOW
105
DELISTED
Bionano Genomics, Inc. Warrant
BNGOW
| – | – |
-10,000
| Closed | -$21K |
|
|
APTX
106
DELISTED
Aptinyx Inc. Common Stock
APTX
| – | – |
-107,536
| Closed | -$372K |
|